Anne Prener

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Lori Firmani, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Prener:

Form 4 holding Director

Rubius Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
Report date
12 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kaleido Biosciences, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
30 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Galecto, Inc.

Security class
Stock Option (right to buy)
Shares / value
720
Estimated value
Report date
18 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Anne Prener

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .